Abstract | INTRODUCTION: MATERIALS AND METHODS: We studied 26 PC patients (Group 1) and 20 patients with benign pancreatic diseases (Group 2). PIVKA-II and CEA were measured by chemiluminescent enzyme immunoassay method (CLEIA) on LUMIPULSE G1200 (Fujirebio-Europe, Gent, Belgium), CA 19-9 and CA 242 were measured by ELSA (CisBio Bioassays, Codolet, France) and EIA (Fujirebio Diagnostics AB, Göteborg, Sweden), respectively. Receiver operating characteristic (ROC) analysis was performed to assess biomarkers' diagnostic characteristics in both groups. RESULTS: Median and interquartile range (IQR) in Group 1 and Group 2 were: 1749.0 (320.2 - 3921.0) vs. 31.0 (23.0 - 43.0) mAU/mL (P < 0.001) for PIVKA-II, 260.0 (158.7 - 272.0) vs. 45.2 (9.0 - 58.0) U/mL (P = 0.034) for CA 19-9, 104.0 (30.2 - 150.0) vs. 7.2 (4.8 - 26.0) U/mL (P < 0.050) for CA 242, 9.4 (5.3 - 37.5) vs. 4.5 (1.8 - 7.0) ng/mL (P = 0.021) for CEA. Areas under the ROC curve of PIVKA-II, CA 19-9, CA 242, CEA were 0.86 (95% CI: 0.71 - 1.00), 0.58 (95% CI: 0.38 - 0.78), 0.73 (95% CI: 0.54 - 0.92), 0.64 (95% CI: 0.44 - 0.85), respectively. CONCLUSIONS:
PIVKA-II is significantly higher in PC than in benign pancreatic diseases. PIVKA-II shows a rather good diagnostic performance compared to CA 19-9, CEA and CA242, thus its determination could help PC management.
|
Authors | Sara Tartaglione, Irene Pecorella, Serena Rita Zarrillo, Teresa Granato, Valentina Viggiani, Lucia Manganaro, Cinzia Marchese, Antonio Angeloni, Emanuela Anastasi |
Journal | Biochemia medica
(Biochem Med (Zagreb))
Vol. 29
Issue 2
Pg. 020707
(Jun 15 2019)
ISSN: 1846-7482 [Electronic] Croatia |
PMID | 31223261
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- Biomarkers
- Biomarkers, Tumor
- Protein Precursors
- acarboxyprothrombin
- Prothrombin
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biomarkers
(blood)
- Biomarkers, Tumor
(blood)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Luminescent Measurements
- Male
- Middle Aged
- Pancreatic Neoplasms
(blood)
- Pilot Projects
- Protein Precursors
(blood)
- Prothrombin
- ROC Curve
|